- Revenues at € 4.3 million 23 % below previous year's level
- EBIT of € 2.0 million (compared to € 2.9 million in the previous year)
- Profit after tax of € 1.5 million (compared to € 4.4 million in the previous year)
Bremen, February 20, 2018 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, announces the results for the first quarter of fiscal year 2017/2018 (reporting period October 1 to December 31, 2017).
Sales in the first quarter of fiscal year 2018 came to € 4,283 k, about 23 % below the previous year (€ 5,537 k). The previous year's figures include the one-time sale of MeVisLab usage rights in the amount of € 1,800 k as part of the service revenues of the Other Diagnostics segment. Revenues from new licenses fell by 13 % to € 1,086 k and maintenance business fell by 4 %. The services business, mainly cloud-based technology - excluding the MeVisLab usage rights - more than doubled with a strong increase to € 1,434 k. Revenues in the Digital Mammography segment increased by 12 % to € 3,003 k (previous year: € 2,660 k), while revenues in the Other Diagnostics segment fell to € 1,280 k (previous year: € 2,877 k), which corresponds to growth of 19 % for this segment - excluding the MeVisLab usage rights.
As a result, an EBIT (earnings before financial result and taxes) of € 1,954 k was generated in the first quarter, compared to € 2,875 k in the first quarter of the previous year. At 46 %, the EBIT margin was slightly lower than the previous year's figure of 52 %.
The financial result declined significantly in the period under review to € -406 k (prev. year: € 1,565 k). In comparison to the previous year, there were significant changes in the balance of income and expenses from exchange rate differences of € -445 k (prev. year: € 1,620 k), as well as in the earnings of the 51 % share in MeVis BreastCare GmbH & Co. KG of € 5 k (prev. year: € -74 k), which is recognized at equity.
Earnings after taxes amounted to € 1,547 k (previous year: € 4,427 k), which corresponds to undiluted earnings per share of € 0.85 (previous year: € 2.43).
The Annual General Meeting of MeVis Medical Solutions AG will be held on March 14, 2018. The interim report for the first half of fiscal year 2017/2018 will be published on May 15, 2018.